 鲜花( 85)  鸡蛋( 2)
|

楼主 |
发表于 2015-2-28 21:48
|
显示全部楼层
Stock soars after Cold-fX wins crucial approval
& F0 b3 ~9 w/ D. ~+ M ) |1 m. g0 Z& Z& ~' P. S5 q
EDMONTON - CV Technologies Inc. shares rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.7 W; R, y4 {* U
% h& o7 j1 R6 @( Y1 ~BY THE EDMONTON JOURNAL FEBRUARY 16, 2007; p0 ]4 F$ P) R# M
6 f. U7 g7 v& G6 K G0 X8 L 4 F- T7 W/ g% N$ |; V3 B+ D
EDMONTON - CV Technologies Inc. SHARES rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.2 |7 Z+ I c1 p. i0 H, X
& N' ]; W% H4 p4 }1 f$ d! kThe agency said CV Technologies can continue to market Cold-fX as helping "to reduce the frequency, severity and duration of cold and flu symptoms by boosting the IMMUNE SYSTEM."9 H4 T8 v, s1 H1 }' I
. _4 i! x$ w1 h; J! G! w
The APPROVAL follows a review of seven clinical trials and more than 10 years of research about the product.+ k/ z1 Z0 J+ [5 }; p/ F. I K
# F9 o+ J+ z9 d6 o# f
It should create even more confidence among consumers and medical professionals that the product works, CEO Jacqueline Shan said Thursday./ k3 q, Z/ V0 B3 I W
: Q% @( c( W. A; A6 ~) D
It certainly instilled confidence in the market, as shares closed at $2.90 on THE TORONTO STOCK EXCHANGE, up $1.08 on a volume of 4.6 million.
, v5 g$ k' k' E1 F, b7 e& R. F( W9 l. e- b
"As a scientist, it's one of the highlights of my CAREER," Shan said.5 H) n" T. d. J9 O$ F- J
& X- C' b! o. @ G& @
"This approval is a breakthrough in realizing our vision of being a global leader in developing products for disease prevention."! M. s3 m' v4 F7 v
* Y# n* o3 X- ~* f$ A" R% s
It's Cold-fX's strongest medical recognition to date, said Shan. It means the company can advertise the HEALTH BENEFITS more effectively to consumers and health professionals, she said.4 Q' Z0 v: ~5 S/ X6 @6 V
4 U: D! R/ E) o" D+ l
Ginseng-based Cold-fX is already the top-selling cold and flu treatment in Canada, but Shan said there is plenty of room for more growth.
' h5 u. e" Z, |
" F# T$ ^9 g; G- g+ z& v7 HThe approval will also help raise the product's PROFILE in the lucrative U.S. market, which Cold-fX entered in October. The move came with a new marketing push, using former Oilers superstar Mark Messier as its spokesman.
! V6 ^& {1 n2 j3 G7 ]/ ?2 e; X* w$ X9 y% K& c7 E
8 z% q0 V; [5 \% V5 [5 uhttp://www.canada.com/story.html ... 9-be80-f40f1426f662 |
|